Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Multi Ways Holdings Reports Financial Results for Fiscal Year 2024
-
Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
-
Veterans-Turned-Tradesmen Use Their Craftsmen Skills and Tools at Hand To Fight Crime and Terrorism On American Soil In Newly Published Action Thriller
-
DeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns Journal
-
Intrado Launches Public Safety Advisory Council to Guide Innovation in 9-1-1 and Emergency Response
-
Emory Healthcare Researchers Use Dynamic Digital Radiography to Compare Shoulder Improvement of Two Surgical Interventions for Massive Irreparable Rotator Cuff Tears
-
authID Announces its 2025 Board of Directors Nominees Ahead of Annual Meeting
-
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
-
Merus to Present at Upcoming Investor Conferences
-
ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC
-
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
-
Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025
-
New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth
-
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
-
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for FLT201, its Clinical-Stage Gene Therapy Candidate in Gaucher Disease
-
MIMEDX to Participate in Upcoming Investor Conferences
-
Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025
-
SSCP Lager Bidco AB (publ) – Interim report for first quarter 2025
-
Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce Completion of Enrollment of the Global Phase 2b Study Evaluating Naronapride in Gastroparesis (MOVE-IT)
-
Camposol Holding PLC reports Preliminary First Quarter 2025 Results.
-
BIO-key and Runlevel Secure First Major IAM Deployment with a National Bank in Mozambique; Extends Growing List of Banking Customers
-
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
-
Disclosure of Shareholding – Gjelsten Holding AS
-
ZLNA – New registered share capital
-
With Support from Solana's Co-Founder Toly, OctonetAI Launches OctoMCP and Prepares for AI-Powered Smart Contract Audits
-
With Support from Solana's Co-Founder Toly, OctonetAI Launches OctoMCP and Prepares for AI-Powered Smart Contract Audits
-
SciSparc Announces Publication of Japanese Patent Application
-
Purpose Investments Inc. Announces Final May 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
-
Evaxion announces business update and first quarter 2025 financial results
-
Urgently Promotes Michael Port to Chief Financial Officer
-
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor
-
American Tungsten Corp. Commences Mine Site Preparation and Exploration Work
-
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
-
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
-
Swvl Secures 3-Year Contract Worth Up to $4 Million with a Large Enterprise in Essential Services
-
ARMLOGI HOLDING CORP. ADDED TO MEMBERSHIP OF RUSSELL MICROCAP® INDEX
-
NETCLASS TECHNOLOGY INC. and East China Normal University Sign Cooperation Agreement to Pioneer a New Era of Smart Education
-
Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies
-
Regula Rolls Out Personal Data Masking Across All Solutions for Easier Privacy Compliance
-
FinWise Bancorp Added to Membership of US Small-Cap Russell 2000® Index
-
Adagene to Present at Jefferies Global Healthcare Conference 2025
-
Nexxen Announced as a Preliminary Addition to the Russell 3000 Index
-
ZA Miner Launches New 3-Day Short-Term Cloud Mining Contracts for May 2025 — Built for XRP Holders Seeking Fast Passive Returns
-
Canstar Ramps Up Critical Minerals Exploration With Initial Payment from $11.5M Strategic Exploration JV
-
Form 8.5 (EPT/RI) - Inspired Plc
-
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities
-
Gilat Receives Over $25 Million in Orders for its Multi-Orbit Satellite Solutions
-
Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
-
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)


